Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERLOTINIB vs IBRUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERLOTINIB vs IBRUTINIB: Safety Overview

Metric ERLOTINIB IBRUTINIB
Total FAERS Reports 22,472 75,087
Deaths Reported 6,791 12,580
Death Rate 30.2% 16.8%
Hospitalizations 3,693 24,920
Average Patient Age 67.2 yrs 71.2 yrs
% Female Patients 59.8% 39.2%
FDA Approval Date Apr 16, 2020 Aug 24, 2022
Manufacturer Zydus Lifesciences Limited Pharmacyclics LLC
Route ORAL ORAL
Marketing Status Discontinued Prescription